Journal of Traditional Medical Complementary Therapies

.: REVIEW
Kemoterapi İlişkili Periferal Nöropati Yönetiminde Kullanılan Tamamlayıcı Tedavi Yaklaşımları: Literatür Derlemesi
Complementary Therapies Used in Chemotherapy Induced Peripheral Neuropathy Management: A Literature Review
Nur İZGÜa
aHacettepe Üniversitesi Hemşirelik Fakültesi, İç Hastalıkları ABD, Ankara, TÜRKİYE
J Tradit Complem Med. 2021;4(2):292-301
doi: 10.5336/jtracom.2020-78520
Article Language: TR
Full Text
ÖZET
 Kemoterapi ilişkili periferal nöropati (KİPN) sık görülen, bireylerin fonksiyonel durumlarını ve yaşam kalitesini olumsuz yönde etkileyen bir tedavi komplikasyonudur. Tamamlayıcı tedaviler, farmakolojik tedavi seçeneklerinin sınırlı olması nedeniyle nöropati semptomlarını hafifletmek için hastalar tarafından sıklıkla tercih edilmektedir. Onkoloji alanında çalışan hemşirelerin, KİPN'nin erken tanılanması ve hastaların fonksiyonel durumlarındaki değişimlere adapte olmalarını kolaylaştırmada önemli rolleri bulunmaktadır. Bu nedenle bu derlemede, KİPN yönetiminde kullanılan meditasyon, reiki, yoga, akupunktur, aromaterapi, masaj, refleksoloji, kriyoterapi ve fiziksel aktivite gibi tamamlayıcı tedavi yaklaşımları, kanıta dayalı araştırma örnekleriyle birlikte ele alınmış ve alanda çalışan hemşirelerin hastalar tarafından kullanılan ve etkisi araştırılan tamamlayıcı tedavilere ilişkin farkındalıklarını artırmak hedeflenmiştir. Bu literatür derlemesi kapsamında incelenen deneysel, yarı deneysel araştırmalar, olgu sunumları ve sistematik derlemeler ele alındığında; KİPN'yi önlemek ya da semptomlarını hafifletmek amacıyla etkisi incelenen tamamlayıcı tedaviler içerisinde zihin beden temelli uygulamalar, akupunktur, aromaterapi, masaj, refleksoloji, kriyoterapi ve fiziksel aktivitenin nöropati semptomlarının önlenmesi veya hafifletilmesinde etkili olabileceği bildirilmiştir. Ancak bu yaklaşımlarla ilgili mevcut klinik araştırma sayısının ve örneklem büyüklüklerinin sınırlı olması, uygulama süresi ve sıklığı açısından farklılıklar içermesi, araştırmaların birbiri ile çelişkili sonuçlar içermesi, uzun süreli etkilerinin bilinmemesi ve kanıta dayalı klinik rehberlerde yer almaması nedeniyle kanıtların yetersiz olduğu düşünülmektedir. KİPN yönetiminde, tamamlayıcı tedavi yaklaşımlarının etkisini inceleyen ve geniş örneklem büyüklüğü ile yürütülen klinik araştırmaların tamamlayıcı tedavilerin klinik kullanımını destekleyecek güçlü kanıtların oluşturulmasına katkı sağlayacağı öngörülmektedir.

Anahtar Kelimeler: Kanser; kemoterapi ilişkili periferal nöropati; tamamlayıcı tedavi
ABSTRACT
 Chemotherapy-induced peripheral neuropathy is a common complication of chemotherapy that limits functional status and negatively affects the quality of life. Due to limited pharmacological treatment options, complementary therapies have been commonly used by the patients to relieve symptoms of chemotherapy-induced peripheral neuropathy. Oncology nurses take an important role in early detection of chemotherapy-induced peripheral neuropathy and facilitating patients to adapt to functional limitations due to chemotherapy-induced peripheral neuropathy. Therefore, in this review complementary therapies, used in the management of chemotherapy-induced peripheral neuropathy, including reiki, yoga, meditation, acupuncture, aromatherapy, massage, reflexology, cryotherapy, and physical activity has been handled with evidence-based research examples, and it has been aimed to heighten awareness of the oncology nurses on this issue. Considering experimental, quasi-experimental research, case reports and systematic reviews examining within the scope of this literature review, mind-body based interventions, acupuncture, aromatherapy, massage, reflexology, cryotherapy, and physical activity have been reported as probably useful in prevention or alleviation of chemotherapy-induced peripheral neuropathy symptoms. On the other hand, clinical evidence is poor due to the limited number of existing studies, small sample size, differences between duration and frequency of applications, uncertainties in long-term effects of complementary therapies, contradictory results among available reports, and lack of recommendations in clinical guidelines on the use of these approaches. It is anticipated that clinical studies with a large sample size will contribute to the development of robust evidence that will support the clinical use of complementary therapies in the management of chemotherapy-induced peripheral neuropathy.

Keywords: Cancer; Chemotherapy-induced peripheral neuropathy; complementary therapy
REFERENCES:
  1. Gutiérrez-Gutiérrez G, Sereno M, Miralles A, Casado-Sáenz E, Gutiérrez-Rivas E. Chemotherapy-induced peripheral neuropathy: clinical features, diagnosis, prevention and treatment strategies. Clin Transl Oncol. 2010;12(2):81-91. [PubMed] 
  2. Kannarkat G, Lasher EE, Schiff D. Neurologic complications of chemotherapy agents. Curr Opin Neurol. 2007;20(6):719-25. [PubMed] 
  3. Windebank AJ, Grisold W. Chemotherapy-induced neuropathy. J Peripher Nerv Syst. 2008;13(1):27-46. [PubMed] 
  4. Argyriou AA, Polychronopoulos P, Iconomou G, Koutras A, Makatsoris T, Gerolymos MK, et al. Incidence and characteristics of peripheral neuropathy during oxaliplatin-based chemotherapy for metastatic colon cancer. Acta Oncol. 2007;46(8):1131-7. [PubMed] 
  5. Seretny M, Currie GL, Sena ES, Ramnarine S, Grant R, MacLeod MR, et al. Incidence, prevalence, and predictors of chemotherapy-induced peripheral neuropathy: A systematic review and meta-analysis. Pain. 2014;155(12):2461-70. [PubMed] 
  6. Pachman DR, Barton DL, Watson JC, Loprinzi CL. Chemotherapy-induced peripheral neuropathy: prevention and treatment. Clin Pharmacol Ther. 2011;90(3):377-87. [PubMed] 
  7. Hershman DL, Lacchetti C, Dworkin RH, Lavoie Smith EM, Bleeker J, Cavaletti G, et al; American Society of Clinical Oncology. Prevention and management of chemotherapy-induced peripheral neuropathy in survivors of adult cancers: American Society of Clinical Oncology clinical practice guideline. J Clin Oncol. 2014;32(18):1941-67. [PubMed] 
  8. Areti A, Yerra VG, Naidu V, Kumar A. Oxidative stress and nerve damage: role in chemotherapy induced peripheral neuropathy. Redox Biol. 2014;2:289-95. [PubMed]  [PMC] 
  9. Starobova H, Vetter I. Pathophysiology of Chemotherapy-Induced Peripheral Neuropathy. Front Mol Neurosci. 2017;10:174. [PubMed]  [PMC] 
  10. Tofthagen C, Visovsky CM, Hopgood R. Chemotherapy-induced peripheral neuropathy: an algorithm to guide nursing management. Clin J Oncol Nurs. 2013;17(2):138-44. [PubMed]  [PMC] 
  11. Visovsky C. Chemotherapy-induced peripheral neuropathy: nursing perspectives. Cancer Investigation. 2003;21(3):439-51. [Link] 
  12. Bakitas MA. Background noise: the experience of chemotherapy-induced peripheral neuropathy. Nurs Res. 2007;56(5):323-31. [PubMed] 
  13. Wickham R. Chemotherapy-induced peripheral neuropathy: a review and implications for oncology nursing practice. Clin J Oncol Nurs. 2007;11(3):361-76. [PubMed] 
  14. Tofthagen C, Donovan KA, Morgan MA, Shibata D, Yeh Y. Oxaliplatin-induced peripheral neuropathy's effects on health-related quality of life of colorectal cancer survivors. Support Care Cancer. 2013;21(12):3307-13. [PubMed]  [PMC] 
  15. Mols F, Beijers T, Vreugdenhil G, van de Poll-Franse L. Chemotherapy-induced peripheral neuropathy and its association with quality of life: a systematic review. Support Care Cancer. 2014;22(8):2261-9. [PubMed] 
  16. Wolf S, Barton D, Kottschade L, Grothey A, Loprinzi C. Chemotherapy-induced peripheral neuropathy: prevention and treatment strategies. Eur J Cancer. 2008;44(11):1507-15. [PubMed] 
  17. Brunelli B, Gorson KC. The use of complementary and alternative medicines by patients with peripheral neuropathy. J Neurol Sci. 2004;218(1-2):59-66. [PubMed] 
  18. Clark PG, Cortese-Jimenez G, Cohen E. Effects of Reiki, yoga, or meditation on the physical and psychological symptoms of chemotherapy-induced peripheral neuropathy: a randomized pilot study. Journal of Evidence-Based Complementary & Alternative Medicine. 2012;17(3):161-71. [Link] 
  19. Franconi G, Manni L, Schröder S, Marchetti P, Robinson N. A systematic review of experimental and clinical acupuncture in chemotherapy-induced peripheral neuropathy. Evid Based Complement Alternat Med. 2013;2013:516916. [PubMed]  [PMC] 
  20. Kleckner IR, Kamen C, Gewandter JS, Mohile NA, Heckler CE, Culakova E, et al. Effects of exercise during chemotherapy on chemotherapy-induced peripheral neuropathy: a multicenter, randomized controlled trial. Support Care Cancer. 2018;26(4):1019-28. [PubMed]  [PMC] 
  21. Hanai A, Ishiguro H, Sozu T, Tsuda M, Yano I, Nakagawa T, et al. Effects of Cryotherapy on Objective and Subjective Symptoms of Paclitaxel-Induced Neuropathy: Prospective Self-Controlled Trial. J Natl Cancer Inst. 2018;110(2):141-8. [PubMed]  [PMC] 
  22. Kurt S, Can G. Reflexology in the management of chemotherapy induced peripheral neuropathy: A pilot randomized controlled trial. Eur J Oncol Nurs. 2018;32:12-19. [PubMed] 
  23. Park R, Park C. Comparison of Foot Bathing and Foot Massage in Chemotherapy-Induced Peripheral Neuropathy. Cancer Nurs. 2015;38(3):239-47. [PubMed] 
  24. Izgu N, Ozdemir L, Bugdayci Basal F. Effect of Aromatherapy Massage on Chemotherapy-Induced Peripheral Neuropathic Pain and Fatigue in Patients Receiving Oxaliplatin: An Open Label Quasi-Randomized Controlled Pilot Study. Cancer Nurs. 2019;42(2):139-147. [PubMed] 
  25. Tavee J, Rensel M, Planchon SM, Butler RS, Stone L. Effects of meditation on pain and quality of life in multiple sclerosis and peripheral neuropathy: a pilot study. Int J MS Care. 2011;13(4):163-8. [PubMed]  [PMC] 
  26. Ledesma D, Kumano H. Mindfulness-based stress reduction and cancer: a meta-analysis. Psychooncology. 2009;18(6):571-9. [PubMed] 
  27. Hussain N, Said ASA. Mindfulness-Based Meditation Versus Progressive Relaxation Meditation: Impact on Chronic Pain in Older Female Patients With Diabetic Neuropathy. J Evid Based Integr Med. 2019;24:2515690X19876599. [Crossref]  [PubMed]  [PMC] 
  28. Speck RM, DeMichele A, Farrar JT, Hennessy S, Mao JJ, Stineman MG, et al. Scope of symptoms and self-management strategies for chemotherapy-induced peripheral neuropathy in breast cancer patients. Support Care Cancer. 2012;20(10):2433-9. [PubMed] 
  29. Galantino ML, Tiger R, Brooks J, Jang S, Wilson K. Impact of Somatic Yoga and Meditation on Fall Risk, Function, and Quality of Life for Chemotherapy-Induced Peripheral Neuropathy Syndrome in Cancer Survivors. Integr Cancer Ther. 2019;18:1534735419850627. [PubMed]  [PMC] 
  30. Kalyon TA. [Acupuncture and pain]. Türkiye Klinikleri Dahili Tıp Bilimleri Dergisi. 2005;1(10):60-4. [Link] 
  31. Bao T, Zhang R, Badros A, Lao L. Acupuncture treatment for bortezomib-induced peripheral neuropathy: a case report. Pain Res Treat. 2011;2011:920807. [PubMed]  [PMC] 
  32. Bao T, Goloubeva O, Pelser C, Porter N, Primrose J, Hester L, et al. A pilot study of acupuncture in treating bortezomib-induced peripheral neuropathy in patients with multiple myeloma. Integr Cancer Ther. 2014;13(5):396-404. [PubMed]  [PMC] 
  33. Donald GK, Tobin I, Stringer J. Evaluation of acupuncture in the management of chemotherapy-induced peripheral neuropathy. Acupunct Med. 2011;29(3):230-3. [PubMed] 
  34. Rostock M, Jaroslawski K, Guethlin C, Ludtke R, Schröder S, Bartsch HH, et al. Chemotherapy-induced peripheral neuropathy in cancer patients: a four-arm randomized trial on the effectiveness of electroacupuncture. Evid Based Complement Alternat Med. 2013;2013:349653. [PubMed]  [PMC] 
  35. Bao T, Seidman AD, Piulson L, Vertosick E, Chen X, Vickers AJ, et al. A phase IIA trial of acupuncture to reduce chemotherapy-induced peripheral neuropathy severity during neoadjuvant or adjuvant weekly paclitaxel chemotherapy in breast cancer patients. Eur J Cancer. 2018;101:12-19. [PubMed]  [PMC] 
  36. Lu W, Giobbie-Hurder A, Freedman RA, Shin IH, Lin NU, Partridge AH, et al. Acupuncture for Chemotherapy-Induced Peripheral Neuropathy in Breast Cancer Survivors: A Randomized Controlled Pilot Trial. Oncologist. 2020;25(4):310-8. [PubMed]  [PMC] 
  37. Li K, Giustini D, Seely D. A systematic review of acupuncture for chemotherapy-induced peripheral neuropathy. Curr Oncol. 2019;26(2):e147-e154. [PubMed]  [PMC] 
  38. Chien TJ, Liu CY, Fang CJ, Kuo CY. The Efficacy of Acupuncture in Chemotherapy-Induced Peripheral Neuropathy: Systematic Review and Meta-Analysis. Integr Cancer Ther. 2019;18:1534735419886662. [PubMed]  [PMC] 
  39. Chien TJ, Liu CY, Fang CJ, Kuo CY. The Efficacy of Acupuncture in Chemotherapy-Induced Peripheral Neuropathy: Systematic Review and Meta-Analysis. Integr Cancer Ther. 2019;18:1534735419886662. [PubMed]  [PMC] 
  40. Halcon LL, Levitan AA. Aromatherapy. Herring MA, Roberts MM, eds. Complemantary and Alternative Medicine Fast Facts for Medical Practice United States of America: Blackwell Publishing; 2002.
  41. Motilal S, Maharaj RG. Nutmeg extracts for painful diabetic neuropathy: a randomized, double-blind, controlled study. J Altern Complement Med. 2013;19(4):347-52. [PubMed] 
  42. Davies SJ, Harding LM, Baranowski AP. A novel treatment of postherpetic neuralgia using peppermint oil. Clin J Pain. 2002;18(3):200-2. [PubMed] 
  43. Gok Metin Z, Arikan Donmez A, Izgu N, Ozdemir L, Arslan IE. Aromatherapy Massage for Neuropathic Pain and Quality of Life in Diabetic Patients. J Nurs Scholarsh. 2017;49(4):379-88. [PubMed] 
  44. Colvin LA, Johnson PR, Mitchell R, Fleetwood-Walker SM, Fallon M. From bench to bedside: a case of rapid reversal of bortezomib-induced neuropathic pain by the TRPM8 activator, menthol. J Clin Oncol. 2008;26(27):4519-20. [PubMed] 
  45. Ghasemzadeh MR, Amin B, Mehri S, Mirnajafi-Zadeh SJ, Hosseinzadeh H. Effect of alcoholic extract of aerial parts of Rosmarinus officinalis L. on pain, inflammation and apoptosis induced by chronic constriction injury (CCI) model of neuropathic pain in rats. J Ethnopharmacol. 2016;194:117-30. [PubMed] 
  46. Abad ANA, Nouri MK, Gharjanie A, Tavakoli F. Effect of Matricaria chamomilla hydroalcoholic extract on cisplatin-induced neuropathy in mice. Chinese Journal of Natural Medicines. 2011;9(2):126-31. [Link] 
  47. Nouri MHK, Abad ANA. Antinociceptive effect of Matricaria chamomilla on vincristine-induced peripheral neuropathy in mice. African Journal of Pharmacy and Pharmacology. 2012;6(1):24-9. [Link] 
  48. Ernst E. Massage therapy for cancer palliation and supportive care: a systematic review of randomised clinical trials. Support Care Cancer. 2009;17(4):333-7. [PubMed] 
  49. Cunningham JE, Kelechi T, Sterba K, Barthelemy N, Falkowski P, Chin SH, et al. Case report of a patient with chemotherapy-induced peripheral neuropathy treated with manual therapy (massage). Support Care Cancer. 2011;19(9):1473-6. [PubMed] 
  50. Coşkun H, Arikan F, Gökdoğan F. Effect of massage therapy on peripheral neuropathy and life quality of colorectal cancer with patient receiving chemotherapy. Annals of Oncology. 2014;25 (Supplement 4): iv517-iv541. [Link] 
  51. Izgu N, Metin ZG, Karadas C, Ozdemir L, Çetin N, Demirci U, et al. Prevention of chemotherapy-induced peripheral neuropathy with classical massage in breast cancer patients receiving paclitaxel: An assessor-blinded randomized controlled trial. Eur J Oncol Nurs. 2019;40:36-43. [PubMed] 
  52. Doğan HD. [Healing art of hand: Reflexology]. European Journal of Basic Medical Sciences. 2014;4(4):89-94. [Link] 
  53. Lee SY, Ham YH, Ok ON, Kim EJ, Kwon IG, Hwang MS, et al. The effects of foot reflexology on peripheral neuropathy, symptom distress, anxiety and depression in cancer patients treated with oxaliplatin. Asian Oncology Nursing. 2012;12(4):305-13. [Link] 
  54. Ben-Horin I, Kahan P, Ryvo L, Inbar M, Lev-Ari S, Geva R, et al. Acupuncture and Reflexology for Chemotherapy-Induced Peripheral Neuropathy in Breast Cancer. Integr Cancer Ther. 2017;16(3):258-62. [PubMed]  [PMC] 
  55. Yang HL, Chen XP, Lee KC, Fang FF, Chao YF. The effects of warm-water footbath on relieving fatigue and insomnia of the gynecologic cancer patients on chemotherapy. Cancer Nurs. 2010;33(6):454-60. [PubMed] 
  56. Kadakia KC, Rozell SA, Butala AA, Loprinzi CL. Supportive cryotherapy: a review from head to toe. J Pain Symptom Manage. 2014;47(6):1100-15. [PubMed]  [PMC] 
  57. Bandla A, Sundar R, Liao LD, Sze Hui Tan S, Lee SC, Thakor NV, et al. Hypothermia for preventing chemotherapy-induced neuropathy - a pilot study on safety and tolerability in healthy controls. Acta Oncol. 2016;55(4):430-6. [PubMed] 
  58. Wilkinson M, Cocilovo C, Vargas HI, Cohen RA, Bruce S, Edmiston KH, et al. Reduction of paclitaxel neuropathy with cryotherapy. American Society of Clinical Oncology. 2016;34(supplement 3). [Link] 
  59. Sato J, Mori M, Nihei S, Kumagai M, Takeuchi S, Kashiwaba M, et al. The effectiveness of regional cooling for paclitaxel-induced peripheral neuropathy. J Pharm Health Care Sci. 2016;2:33. [PubMed]  [PMC] 
  60. Shigematsu H, Hirata T, Nishina M, Yasui D, Ozaki S. Cryotherapy for the prevention of weekly paclitaxel-induced peripheral adverse events in breast cancer patients. Support Care Cancer. 2020;28(10):5005-11. [PubMed]  [PMC] 
  61. Ruddy KJ, Le-Rademacher J, Lacouture ME, Wilkinson M, Onitilo AA, Vander Woude AC, et al. Randomized controlled trial of cryotherapy to prevent paclitaxel-induced peripheral neuropathy (RU221511I); an ACCRU trial. Breast. 2019;48:89-97. [PubMed]  [PMC] 
  62. Kanbayashi Y, Sakaguchi K, Ishikawa T, Ouchi Y, Nakatsukasa K, Tabuchi Y, et al. Comparison of the efficacy of cryotherapy and compression therapy for preventing nanoparticle albumin-bound paclitaxel-induced peripheral neuropathy: A prospective self-controlled trial. Breast. 2020;49:219-24. [PubMed]  [PMC] 
  63. Sundar R, Bandla A, Tan SS, Liao LD, Kumarakulasinghe NB, Jeyasekharan AD, et al. Limb Hypothermia for Preventing Paclitaxel-Induced Peripheral Neuropathy in Breast Cancer Patients: A Pilot Study. Front Oncol. 2017;6:274. [PubMed]  [PMC] 
  64. Sundar R, Bandla A, Tan SS, Liao LD, Kumarakulasinghe NB, Jeyasekharan AD, et al. Limb Hypothermia for Preventing Paclitaxel-Induced Peripheral Neuropathy in Breast Cancer Patients: A Pilot Study. Front Oncol. 2017;6:274. [PubMed]  [PMC] 
  65. Asensio-Pinilla E, Udina E, Jaramillo J, Navarro X. Electrical stimulation combined with exercise increase axonal regeneration after peripheral nerve injury. Exp Neurol. 2009;219(1):258-65. [PubMed] 
  66. Balducci S, Iacobellis G, Parisi L, Di Biase N, Calandriello E, Leonetti F, et al. Exercise training can modify the natural history of diabetic peripheral neuropathy. J Diabetes Complications. 2006;20(4):216-23. [PubMed] 
  67. Allet L, Armand S, de Bie RA, Golay A, Monnin D, Aminian K, et al. The gait and balance of patients with diabetes can be improved: a randomised controlled trial. Diabetologia. 2010;53(3):458-66. [PubMed]  [PMC] 
  68. Fernandes J, Kumar S. Effect of lower limb closed kinematic chain exercises on balance in patients with chemotherapy-induced peripheral neuropathy: a pilot study. Int J Rehabil Res. 2016;39(4):368-71. [PubMed] 
  69. Mols F, Beijers AJ, Vreugdenhil G, Verhulst A, Schep G, Husson O, et al. Chemotherapy-induced peripheral neuropathy, physical activity and health-related quality of life among colorectal cancer survivors from the PROFILES registry. J Cancer Surviv. 2015;9(3):512-22. [PubMed] 
  70. Wonders KY, Whisler G, Loy H, Holt B, Bohachek K, Wise R, et al. Ten Weeks of Home-Based Exercise Attenuates Symptoms of Chemotherapy-Induced Peripheral Neuropathy in Breast Cancer Patients. Health Psychol Res. 2013;1(3):e28. [PubMed]  [PMC] 
  71. Kanzawa-Lee G, Krauss JC, Ploutz-Snyder R, Larson J, Resnicow K, Lievense A, et al. Moderate to vigorous physical activity effect on chemotherapy-induced peripheral neuropathy. American Society of Clinical Oncology. 2020;38( supplement 15). [Link] 
  72. Zimmer P, Trebing S, Timmers-Trebing U, Schenk A, Paust R, Bloch W, et al. Eight-week, multimodal exercise counteracts a progress of chemotherapy-induced peripheral neuropathy and improves balance and strength in metastasized colorectal cancer patients: a randomized controlled trial. Support Care Cancer. 2018;26(2):615-24. [PubMed] 
  73. Duregon F, Vendramin B, Bullo V, Gobbo S, Cugusi L, Di Blasio A, et al. Effects of exercise on cancer patients suffering chemotherapy-induced peripheral neuropathy undergoing treatment: A systematic review. Crit Rev Oncol Hematol. 2018;121:90-100. [PubMed] 
  74. Kanzawa-Lee GA, Larson JL, Resnicow K, Smith EML. Exercise Effects on Chemotherapy-Induced Peripheral Neuropathy: A Comprehensive Integrative Review. Cancer Nurs. 2020;43(3):E172-E185. [PubMed] 

.: Up To Date

Login

 Forgot your password?

 New Registration  

Contact

Ortadoğu Reklam Tanıtım Yayıncılık Turizm Eğitim İnşaat Sanayi ve Ticaret A.Ş.

.: Address

Turkocagi Caddesi No:30 06520 Balgat / ANKARA
Phone: +90 312 286 56 56
Fax: +90 312 220 04 70
E-mail: info@turkiyeklinikleri.com

.: Manuscript Editing Department

Phone: +90 312 286 56 56/ 2
E-mail: yaziisleri@turkiyeklinikleri.com

.: English Language Redaction

Phone: +90 312 286 56 56/ 145
E-mail: tkyayindestek@turkiyeklinikleri.com

.: Marketing Sales-Project Department

Phone: +90 312 286 56 56/ 142
E-mail: reklam@turkiyeklinikleri.com

.: Subscription and Public Relations Department

Phone: +90 312 286 56 56/ 118
E-mail: abone@turkiyeklinikleri.com

.: Customer Services

Phone: +90 312 286 56 56/ 118
E-mail: satisdestek@turkiyeklinikleri.com

1. TERMS OF USE

1.1. To use the web pages with http://www.turkiyeklinikleri.com domain name or the websites reached through the sub domain names attached to the domain name (They will be collectively referred as "SITE"), please read the conditions below. If you do not accept these terms, please cease to use the "SITE." "SITE" owner reserves the right to change the information on the website, forms, contents, the "SITE," "SITE" terms of use anytime they want.

1.2. The owner of the "SITE" is Ortadoğu Advertisement Presentation Publishing Tourism Education Architecture Industry and Trade Inc. (From now on it is going to be referred as "Turkiye Klinikleri", shortly) and it resides at Turkocagi cad. No:30, 06520 Balgat Ankara. The services in the "SITE" are provided by "Turkiye Klinikleri."

1.3. Anyone accessing the "SITE" with or without a fee whether they are a natural person or a legal identity is considered to agree these terms of use. In this contract hereby, "Turkiye Klinikleri" may change the stated terms anytime. These changes will be published in the "SITE" periodically and they will be valid when they are published. Any natural person or legal identity benefiting from and reaching to the "SITE" are considered to be agreed to any change on hereby contract terms done by "Turkiye Klinikleri."

1.4. The "Terms of Use" hereby is published in the website with the last change on March 30th 2014 and the "SITE" is activated by enabling the access to everyone. The "Terms of Use" hereby is also a part of the any "USER Contract" was and/or will be done with the users using "Turkiye Klinikleri" services with or without a fee an inseparable.

2. DEFINITIONS

2.1. "SITE": A website offering different kind of services and context with a certain frame determined by "Turkiye Klinikleri" and it is accessible on-line on http://www.turkiyeklinikleri.com domain name and/or subdomains connected to the domain name.

2.2. USER: A natural person or a legal identity accessing to the "SITE" through online settings.

2.3. LINK: A link enabling to access to another website through the "SITE", the files, the context or through another website to the "SITE", the files and the context.

2.4. CONTEXT: Any visual, literary and auditory images published in the "Turkiye Klinikleri", "SITE" and/or any website or any accessible information, file, picture, number/figures, price, etc.

2.5. "USER CONTRACT": An electronically signed contract between a natural or a legal identity benefiting from special services "Turkiye Klinikleri" will provide and "Turkiye Klinikleri".

3. SCOPE OF THE SERVICES

3.1. "Turkiye Klinikleri" is completely free to determine the scope and quality of the services via the "SITE".

3.2. To benefit the services of "Turkiye Klinikleri" "SITE", the "USER" must deliver the features that will be specified by "Turkiye Klinikleri". "Turkiye Klinikleri" may change this necessity any time single-sided.

3.3. Not for a limited number, the services "Turkiye Klinikleri" will provide through the "SITE" for a certain price or for free are;

- Providing scientific articles, books and informative publications for health industry.

- Providing structural, statistical and editorial support to article preparation stage for scientific journals.

4. GENERAL PROVISIONS

4.1. "Turkiye Klinikleri" is completely free to determine which of the services and contents provided in the "SITE" will be charged.

4.2. People benefiting from the services provided by "Turkiye Klinikleri" and using the website can use the "SITE" only according to the law and only for personal reasons. Users have the criminal and civil liability for every process and action they take in the "SITE". Every USER agrees, declares and undertakes that they will not proceed by any function or action infringement of rights of "Turkiye Klinikleri"s and/or other third parties', they are the exclusive right holder on usage, processing, storage, made public and revealing any written, visual or auditory information reported to Turkiye Klinikleri" and/or "SITE" to the third parties. "USER" agrees and undertakes that s/he will not duplicate, copy, distribute, process, the pictures, text, visual and auditory images, video clips, files, databases, catalogs and lists within the "SITE", s/he will not be using these actions or with other ways to compete with "Turkiye Klinikleri", directly or indirectly.

4.3. The services provided and the context published within the "SITE" by third parties is not under the responsibility of "Turkiye Klinikleri", institutions collaborated with "Turkiye Klinikleri", "Turkiye Klinikleri" employee and directors, "Turkiye Klinikleri" authorized salespeople. Commitment to accuracy and legality of the published information, context, visual and auditory images provided by any third party are under the full responsibility of the third party. "Turkiye Klinikleri" does not promise and guarantee the safety, accuracy and legality of the services and context provided by a third party.

4.4. "USER"s cannot act against "Turkiye Klinikleri", other "USER"s and third parties by using the "SITE". "Turkiye Klinikleri" has no direct and/or indirect responsibility for any damage a third party suffered or will suffer regarding "USER"s actions on the "SITE" against the rules of the hereby "Terms of Use" and the law.

4.5. "USER"s accept and undertake that the information and context they provided to the "SITE" are accurate and legal. "Turkiye Klinikleri" is not liable and responsible for promising and guaranteeing the verification of the information and context transmitted to "Turkiye Klinikleri" by the "USER"s, or uploaded, changed and provided through the "SITE" by them and whether these information are safe, accurate and legal.

4.6. "USER"s agree and undertake that they will not perform any action leading to unfair competition, weakening the personal and commercial credit of "Turkiye Klinikleri" and a third party,  encroaching and attacking on personal rights within the "SITE" in accordance with the Turkish Commercial Code Law.

4.7. "Turkiye Klinikleri" reserves the right to change the services and the context within the "SITE"  anytime. "Turkiye Klinikleri" may use this right without any notification and timelessly. "USER"s have to make the changes and/or corrections "Turkiye Klinikleri" required immediately. Any changes and/or corrections that are required by "Turkiye Klinikleri", may be made by "Turkiye Klinikleri" when needed. Any harm, criminal and civil liability resulted or will result from changes and/or corrections required by "Turkiye Klinikleri" and were not made on time by the "USER"s belongs completely to the users.

4.8. "Turkiye Klinikleri" may give links through the "SITE" to other websites and/or "CONTEXT"s and/or folders that are outside of their control and owned and run by third parties. These links are provided for ease of reference only and do not hold qualification for support the respective web SITE or the admin or declaration or guarantee for the information inside. "Turkiye Klinikleri" does not hold any responsibility over the web-sites connected through the links on the "SITE", folders and context, the services or products on the websites provided through these links or their context.

4.9. "Turkiye Klinikleri" may use the information provided to them by the "USERS" through the "SITE" in line with the terms of the "PRIVACY POLICY" and "USER CONTRACT". It may process the information or classify and save them on a database. "Turkiye Klinikleri" may also use the USER's or visitor's identity, address, e-mail address, phone number, IP number, which sections of the "SITE" they visited, domain type, browser type, date and time information to provide statistical evaluation and customized services.

5. PROPRIETARY RIGHTS

5.1. The information accessed through this "SITE" or provided by the users legally and all the elements (including but not limited to design, text, image, html code and other codes) of the "SITE" (all of them will be called as studies tied to "Turkiye Klinikleri"s copyrights) belongs to "Turkiye Klinikleri". Users do not have the right to resell, process, share, distribute, display or give someone permission to access or to use the "Turkiye Klinikleri" services, "Turkiye Klinikleri" information and the products under copyright protection by "Turkiye Klinikleri". Within hereby "Terms of Use" unless explicitly permitted by "Turkiye Klinikleri" nobody can reproduce, process, distribute or produce or prepare any study from those under "Turkiye Klinikleri" copyright protection.

5.2. Within hereby "Terms of Use", "Turkiye Klinikleri" reserves the rights for "Turkiye Klinikleri" services, "Turkiye Klinikleri" information, the products associated with "Turkiye Klinikleri" copyrights, "Turkiye Klinikleri" trademarks, "Turkiye Klinikleri" trade looks or its all rights for other entity and information it has through this website unless it is explicitly authorized by "Turkiye Klinikleri".

6. CHANGES IN THE TERMS OF USE

"Turkiye Klinikleri" in its sole discretion may change the hereby "Terms of Use" anytime announcing within the "SITE". The changed terms of the hereby "Terms of Use" will become valid when they are announced. Hereby "Terms of Use" cannot be changed by unilateral declarations of users.

7. FORCE MAJEURE

"Turkiye Klinikleri" is not responsible for executing late or never of this hereby "Terms of Use", privacy policy and "USER Contract" in any situation legally taken into account as force majeure. Being late or failure of performance or non-defaulting of this and similar cases like this will not be the case from the viewpoint of "Turkiye Klinikleri", and "Turkiye Klinikleri" will not have any damage liability for these situations. "Force majeure" term will be regarded as outside of the concerned party's reasonable control and any situation that "Turkiye Klinikleri" cannot prevent even though it shows due diligence. Also, force majeure situations include but not limited to natural disasters, rebellion, war, strike, communication problems, infrastructure and internet failure, power cut and bad weather conditions.

8. LAW AND AUTHORISATION TO FOLLOW

Turkish Law will be applied in practicing, interpreting the hereby "Terms of Use" and managing the emerging legal relationships within this "Terms of Use" in case of finding element of foreignness, except for the rules of Turkish conflict of laws. Ankara Courts and Enforcement Offices are entitled in any controversy happened or may happen due to hereby contract.

9. CLOSING AND AGREEMENT

Hereby "Terms of Use" come into force when announced in the "SITE" by "Turkiye Klinikleri". The users are regarded to agree to hereby contract terms by using the "SITE". "Turkiye Klinikleri" may change the contract terms and the changes will be come into force by specifying the version number and the date of change on time it is published in the "SITE".

 

30.03.2014

Privacy Policy

We recommend you to read the terms of use below before you visit our website. In case you agree these terms, following our rules will be to your favor. Please read our Terms of Use thoroughly.

www.turkiyeklinikleri.com website belongs to Ortadoğu Advertisement Presentation Publishing Tourism Education Architecture Industry and Trade Inc. and is designed in order to inform physicians in the field of health

www.turkiyeklinikleri.com cannot reach to user’s identity, address, service providers or other information. The users may send this information to the website through forms if they would like to. However, www.turkiyeklinikleri.com may collect your hardware and software information. The information consists of your IP address, browser type, operating system, domain name, access time, and related websites. www.turkiyeklinikleri.com cannot sell the provided user information (your name, e-mail address, home and work address, phone number) to the third parties, publish it publicly, or keep it in the website. Gathered information has a directing feature to be a source for the website’s visitor profile, reporting and promotion of the services.

www.turkiyeklinikleri.com uses the taken information:

-To enhance, improve and maintain the quality of the website

-To generate visitor’s profile and statistical data

-To determine the tendency of the visitors on using our website

-To send print publications/correspondences

-To send press releases or notifications through e-mail

-To generate a list for an event or competition

By using www.turkiyeklinikleri.com you are considered to agree that;

-Ortadoğu Advertisement Presentation Publishing Tourism Education Architecture Industry and Trade Inc. cannot be hold responsible for any user’s illegal and immoral behavior,

-Terms of use may change from time to time,

-It is not responsible for other websites’ contents it cannot control or the harms they may cause although it uses the connection they provided.

Ortadoğu Advertisement Presentation Publishing Tourism Education Architecture Industry and Trade Inc. may block the website to users in the following events:

-Information with wrong, incomplete, deceiving or immoral expressions is recorded to the website,

-Proclamation, advertisement, announcement, libelous expressions are used against natural person or legal identity,

-During various attacks to the website,

-Disruption of the website because of a virus.

Written, visual and audible materials of the website, including the code and the software are under protection by legal legislation.

Without the written consent of Ortadoğu Advertisement Presentation Publishing Tourism Education Architecture Industry and Trade Inc. the information on the website cannot be downloaded, changed, reproduced, copied, republished, posted or distributed.

All rights of the software and the design of the website belong to Ortadoğu Advertisement Presentation Publishing Tourism Education Architecture Industry and Trade Inc.

Ortadoğu Advertisement Presentation Publishing Tourism Education Architecture Industry and Trade Inc. will be pleased to hear your comments about our terms of use. Please share the subjects you think may enrich our website or if there is any problem regarding our website.

info@turkiyeklinikleri.com